Education
About Us
Working with TipRanks
Follow Us
Elekta AB (SE:EKTA.B)
:EKTA.B
EKTA.B Stock Chart & Stats
kr56.95
-kr1.10(-1.86%)
At close: 4:00 PM EST
kr56.95
-kr1.10(-1.86%)
Day’s Range― - ―
52-Week Rangekr40.64 - kr66.70
Previous CloseN/A
Volume166.39K
Average Volume (3M)1.33M
Market Cap
kr21.24B
Enterprise Valuekr26.52B
Total Cash (Recent Filing)kr2.58B
Total Debt (Recent Filing)kr8.46B
Price to Earnings (P/E)73.0
Beta1.29
Next Earnings
Mar 05, 2026EPS Estimate
0.48Next Dividend Ex-DateN/A
Dividend Yield4.25%
Share Statistics
EPS (TTM)0.64
Shares Outstanding368,587,650
10 Day Avg. Volume896,136
30 Day Avg. Volume1,329,676
Financial Highlights & Ratios
PEG Ratio-0.97
Price to Book (P/B)2.13
Price to Sales (P/S)1.04
P/FCF Ratio17.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr49.67Price Target Upside-12.79% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash Flow GenerationStrong cash flow growth indicates Elekta's ability to generate cash efficiently, supporting reinvestment in innovation and debt servicing.
Balanced Capital StructureA balanced capital structure provides Elekta with financial flexibility to pursue strategic investments and withstand economic fluctuations.
Stable Gross Profit MarginConsistent gross margins reflect effective cost management, allowing Elekta to maintain profitability despite market challenges.
Bears Say
Negative Revenue GrowthNegative revenue growth suggests potential market challenges or competitive pressures, impacting Elekta's ability to expand its market share.
Declining Profitability MarginsReduced net profit margins indicate challenges in maintaining profitability, which could affect Elekta's long-term financial health.
Decreased Return On EquityLower return on equity reflects reduced profitability from equity investments, potentially impacting investor confidence and future capital raising.
Elekta AB News
EKTA.B FAQ
What was Elekta AB’s price range in the past 12 months?
Elekta AB lowest stock price was kr40.64 and its highest was kr66.70 in the past 12 months.
What is Elekta AB’s market cap?
Elekta AB’s market cap is kr21.24B.
When is Elekta AB’s upcoming earnings report date?
Elekta AB’s upcoming earnings report date is Mar 05, 2026 which is in 10 days.
How were Elekta AB’s earnings last quarter?
Elekta AB released its earnings results on Nov 26, 2025. The company reported kr0.64 earnings per share for the quarter, beating the consensus estimate of kr0.611 by kr0.029.
Is Elekta AB overvalued?
According to Wall Street analysts Elekta AB’s price is currently Overvalued.
Does Elekta AB pay dividends?
Elekta AB pays a Semiannually dividend of kr1.2 which represents an annual dividend yield of 4.25%. See more information on Elekta AB dividends here
What is Elekta AB’s EPS estimate?
Elekta AB’s EPS estimate is 0.48.
How many shares outstanding does Elekta AB have?
Elekta AB has 368,587,650 shares outstanding.
What happened to Elekta AB’s price movement after its last earnings report?
Elekta AB reported an EPS of kr0.64 in its last earnings report, beating expectations of kr0.611. Following the earnings report the stock price went up 23.485%.
Which hedge fund is a major shareholder of Elekta AB?
Currently, no hedge funds are holding shares in SE:EKTA.B
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Elekta AB
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
EKTA.B Stock 12 Month Forecast
Average Price Target
kr49.67
▼(-12.79% Downside)
Technical Analysis
Vitrolife AB
―
Camurus AB
―
RaySearch Laboratories AB
―
C-Rad AB Class B
―
MedCap AB
―
Options Prices
Currently, No data available
---